Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009 (2009), Article ID 183760, 5 pages
http://dx.doi.org/10.1155/2009/183760
Research Article

Regulation of Chemokine Production via Oxidative Pathway in HeLa Cells

Department of Clinical Neuroscience Oral and Maxillofacial Functional Rehabilitation, University of Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan

Received 23 June 2009; Accepted 3 November 2009

Academic Editor: Hidde Bult

Copyright © 2009 Shinichiro Kina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Inflammation is associated with disease progression and, by largely unknown mechanisms, has been said to drive oncogenesis. At inflamed sites, neutrophils deploy a potent antimicrobial arsenal that includes proteinases, antimicrobial peptides, and ROS. Reactive oxygen species (ROSs) induce chemokines. In the present study, the concentrations of IL-8 in culture supernatants of HeLa cells treated with ROS were determined by enzyme-linked immunosorbent assay. We used -phenanthroline to deplete in order to investigate the mechanisms through which ROSs induce IL-8 secretion in our system. The iron chelator -phenanthroline effectively inhibited -induced ERK2 activation. Enzyme-linked immunosorbent assays showed that IL-8 protein secretion was elevated in ROS-treated HeLa cells. When was removed from these cells, IL-8 secretion was inhibited. Collectively, these results indicate that -mediated Erk pathway activation is an important signal transduction pathway in ROS-induced IL-8 secretion in epithelial cells.

1. Introduction

Inflammation is associated with disease progression and, by largely unknown mechanisms, has been said to lead to drive oncogenesis. At inflamed sites, neutrophils deploy a potent antimicrobial arsenal that includes proteinases, antimicrobial peptides, and ROS [1]. Although ROSs are potently antimicrobial by virtue of their ability to kill microbial pathogens, in chronic inflammation, the continued production of ROS by neutrophils causes extensive tissue damage. Traditionally, this has been considered as random damage to cellular components [2]. Recently, ROSs have emerged as signal transduction molecules [3, 4].

In inflammatory cells, ROSs contribute to the expression of a variety of different inflammatory cytokines, adhesion molecules, and enzymes by activating redox-sensitive transcription factors such as nuclear factor-kB (NF-kB) or the AP-1 pathway [3, 5, 6]. In human monocytes, IL-8 production is induced by ROS, including by via Erk-activated NF-kB [6].

Moreover, metal ion, such as iron, may take part in an important role in IL-8 production. The levels of iron in the cell seem to be delicately balanced, as iron loadings lead to free radical damage by the Fenton reaction [3]. In this study, our experiments were designed to determine the role of metal ions in the production of IL-8 by epithelial cells treated with ROS.

IL-8 has a molecular weight of 8.5 kDa and is of clinical significance in oral cancer diagnosis [7]. Oral cancer, the sixth most common cancer in the world, comprises the largest number of cancers in the head and neck category. The survival rate of oral cancer patients is 60%–80% when detected during its early stages; however, this number drops to 30%–40% when the cancer is diagnosed during advanced stages [8]. Identifying molecular markers of early disease can aid in its early diagnosis, which can improve the prognosis [9]. IL-8, as a salivary biomarker for early-stage oral squamous cell carcinoma (OSCC), was discovered through tissue-based expression profiling [7, 10]. Moreover, IL-8 plays a pivotal role in tumor angiogenesis [11, 12]. Fujimoto et al. reported a significant correlation between microvessel counts and interleukin- (IL-)8 levels in uterine cervical cancer [13].

Herein, we show that iron controls H2O2-induced chemokine expression in epithelial cells. In HeLa cells, hydrogen peroxide ( ) causes iron oxidation and amplifies Erk signaling. This elicits the expression of the chemokine interleukin-8 (IL-8).

2. Methods

2.1. Reagents

EGTA, PD98059 (p44/42 MAPKK inhibitor) and o-phenanthroline were purchased from Sigma-Aldrich (St Louis, MO, USA).

2.2. Cell Culture

The human cervical cancer cell line HeLa was routinely cultured in RPMI 1640 (Gibco) medium supplemented with 5% fetal bovine serum (Sigma), 40 units/mL penicillin, and 40 mg/mL streptomycin at C under 5%   . Serum starvation was achieved by incubation in RPMI medium containing 0.5% fetal bovine serum for at least 16 hours prior to the direct addition of to this culture medium. To observe the effect of Erk pathway inhibitors and agents to chelate Fe2+ on the secretion of IL-8 by HeLa cells, o-phenanthroline (0.2 mM), and mannitol (100 mM) were added to the culture medium 45 minutes before the direct addition of . Following further culturing for 12 hours, the supernatants from HeLa cells were collected and analyzed.

2.3. RT-PCR

Total RNA was extracted using Trizol (Invitrogen). The reverse-transcription of RNA to cDNA was performed using the RNA LA PCR Kit (TaKaRa). Expression levels of IL-8 and GAPDH mRNA in the HeLa cells were determined by RT-PCR using specific primers (invitrogen): -CTGATTTCTGCAGCTCTGTG- (sense) and -TTCACTGGCATCTTCACTG- (anti-sense) for IL-8, and -CAGGGCTGCTTTTAACTCTG- (sense) and -GATGATCTTGAGGCTGTTGTC- (anti-sense) for GAPDH. Temperature cycles were as follows: C for 1 minute, followed by 28 cycles at C for 30 seconds, C for 30 seconds, and C for 35 seconds for CXCL8, and 20 cycles at C for 30 seconds, C for 30 seconds, and C for 35 seconds for GAPDH. The primers used for real-time PCR are -ACTCCAAACCTTTCCACCC- (sense) and -AAACTTCTCCACAACCCTCTG- (antisense) for IL-8, and -GAAGGTGAAGGTCGGAGTC- (sense) and -GAAGATGGTGATGGGATTTC- (antisense) for human GAPDH mRNA. SYBR Green PCR master mixes on the 7000 real-time PCR system (Applied Biosystem).

2.4. Western Blot Analysis

We determined Erk activation, by Western blotting with mouse monoclonal phospho-Erk1/2-specific antibody (Cell Signaling) using the ECL system (Amersham Pharmacia Biotech). Cells were washed once with PBS and lysed in TNE lysis buffer (10 mM Tris-HCl (pH7.8), 150 mM NaCl, 1 mM EDTA, and 1% NP40 ) supplemented with a protease and phosphatase inhibitor cocktail (Roche) for 10 minutes on ice. After centrifugation at 15,000 rpm for 10 minutes, lysates were subjected to 10% SDS-PAGE and electrotransferred onto a nitrocellulose membrane. The total amount of Erk2 was detected by using mouse monoclonal Erk2-specific antibody (Santa Cruz Biotech).

2.5. Determination of IL-8 Concentration

We determined the concentrations of IL-8 from HeLa cells by ELISA according to the manufacturer’s instructions (Biolegend).

2.6. Statistical Analyses

All data are expressed as means s.e.m. We accumulated data for each condition from at least three independent experiments. We evaluated the significance using Student’s t-test for comparisons between two mean values. We carried out multiple comparisons between more than three groups with ANOVA followed by the Tukey-Kramer test.

3. Results

3.1. Activates ERK and Induces IL-8 Expression

Guyton et al. previously demonstrated that activated Erk2 based on the direct measurement of kinase activity by employing the immune complex kinase assay [4]. However, based on other reports showing that Erk1 is more strongly activated than Erk2 after treatment with [6], we would expect Erk1 to be a more activated kinase in our system in the presence of same stimulation, as described in other reports. To observe Erk activity, we assessed the level of phospho-Erk after treatment. As shown in Figure 1(a), stimulated the rapid and transient phosphorylation of Erk in HeLa cells. Erk activation was induced by within 5 minutes for Erk2 and 10 minutes for Erk1, reaching maximum levels after 10–20 minutes (Figure 1(a)). A rapid inactivation of ERK2 then took place, with a return to basal Erk2 levels occurring within 60 minutes of exposure. Unexpectedly, Erk2 becomes more phosphorylated than Erk1 in HeLa cells after treatment.

fig1
Figure 1: Time course of the activation of Erk and IL-8 production by . (a) Activated Erk: phosphorylated Erk1/2 induced by 0.25 mM at the indicated time points of treatment. (b) Expression levels of IL-8 mRNA induced by incubation with 0.25 mM at the indicated time points.

In epithelial cells, ROSs contribute to the expression of a variety of different inflammatory cytokines by activating redox-sensitive transcription factors such as AP-1 [5]. We investigated the effect of on the expression of IL-8. As shown in Figure 1(b), treatment stimulated a transient but marked increase in the mRNA expression of IL-8.

3.2. Effect of Erk Activation on IL-8 Production following Exposure

In HeLa cells, treatment with induced the mRNA expression of IL-8 (Figure 1(b)). In further experiments, we used ELISA to measure the IL-8 concentrations in culture supernatants from HeLa cells treated with . Consistent with previous reports, IL8 mRNA expression and secretion were suppressed by the Erk pathway inhibitor PD98059 (Figure 2) [1416]. These results show that the Erk pathway controls -induced IL-8 production in HeLa cells.

fig2
Figure 2: Erk controls -induced IL-8 expression in HeLa cells. The inhibitory effect of PD98059 on -induced expression (0.25 mM) of IL-8 mRNA ((a) real-time PCR) and protein secretion ((b) ELISA). Data points are means s.e.m. * .01 ( ).
3.3. Role of Free Radicals in Initiation of Erk Signaling and IL-8 Production Caused by

The chemical signal generated by that initiates the ERK cascade was also investigated. The iron chelator o-phenanthroline effectively inhibited ERK activation caused by (Figure 3(a)), suggesting that metal-dependent reactions are required for kinase activation by . In the presence of metal ions, can undergo conversion via dismutation reactions to other oxygen-derived free radical species, including the hydroxyl radical [17]. Indeed, mannitol, a free radical scavenger with specificity for hydroxyl radicals [4], also blocked -mediated ERK2 activation. Taken together, these results suggest that undergoes metal-catalyzed conversion to a hydroxyl radical-like species, and that oxidation by this free radical initiates signal transduction leading to ERK activation by . In contrast, -induced ERK activation was unaffected by the calcium chelator, EGTA.

fig3
Figure 3: The role of free radicals in -mediated Erk2 activation and IL-8 production. (a) Mannitol (100 mM), o-phenanthroline (0.2 mM), or EGTA (2.5 mM) was added 45 minutes before direct addition of , and cells were harvested 15 minutes later for the analysis of p-Erk1/2 activity for the western blot. The inhibitors alone did not activate Erk1/2. (b) The inhibitory effects of o-phenanthroline on -induced expression (0.25 mM) of IL-8 protein secretion (ELISA) * .01 ( ).

Fe2+ ion has been implicated in the activation of the Erk pathway. Therefore, it was considered possible that Fe2+ ion transduces the regulation of -induced IL-8 secretion. To address this, we investigated whether the depletion of Fe2+ reduced IL-8 secretion from HeLa cells treated with . HeLa cells were treated with 200  M of o-phenanthroline or cultured in serum starved medium for 45 minutes prior to exposure. -induced IL-8 production in HeLa cells was inhibited by the removal of Fe2+ (Figure 3(b)), suggesting that Fe2+ ion is key in -induced IL-8 production.

Taken together, these results indicate that the levels of IL-8 produced by HeLa cells are predominantly controlled by the oxidative pathway.

 Surprisingly, o-phenanthroline itself induced IL-8 secretion. So, we concluded that iron balance is very important for IL-8 production.

4. Discussion

It has been postulated that chemokine production by monocytes in response to requires Erk pathway activation via Ca2+ channel-mediated Ca2+ influx [6, 18]. However, our studies on epithelial cells seemed to indicate no inhibitory effect on Erk pathway activation after the removal of extracellular Ca2+ on treating HeLa cells with . In this study, we examined the inhibitory effects of other metal ion chelators on IL-8 production in epithelial cells in response to , with the aim of elucidating the nature of the hydroxyl radical reaction. Thus, by varying the metal ion chelator, we can obtain new insights into role of other metal ions in chemokine production. Furthermore, these studies have important implications regarding optimal parameters for oral cancer screening [19].

Under conditions in which is maintained at a relatively low level (250  M), it did not induce cell death, as described in other reports [6, 20]. The primary determinant of chemokine production is Erk activation, and, hence, HeLa cells express mRNA of IL-8 on treatment. However, it is likely that the nature of Erk pathway activation, such as Erk1 or Erk2 specificity, slightly differs between monocytes and HeLa cells.

Under conditions in which monocytes are exposed to    , Ca2+ influx occurs through Ca2+ channels, and, as a result, the Erk pathway, especially Erk1, is activated [6]. After the removal of Ca2+ using EGTA, Erk1 activation with  treatment is inhibited in monocytes [6]. On the contrary, when HeLa cells are exposed to at the same level (250  M), the Erk pathway, especially Erk2, is activated.

We predicted that the suppression of IL-8 transcription inhibits the subsequent steps in IL-8 secretion. To test this, we pretreated -exposed HeLa cells with PD98059 and measured IL-8 secretion. Although the -exposed HeLa cells showed an increase in IL-8 secretion, this secretion was significantly inhibited in PD98059-treated HeLa cells. These results support the proposal that Erk mediates IL-8 secretion.

In an effort to define the mechanism by which regulates chemokine production, we examined the inhibitory effect of metal ion chelators on Erk pathway activation. Whereas EGTA showed no inhibitory effect on Erk pathway activation in HeLa cells, the level of phospho-Erk in HeLa cells pretreated with o-phenanthroline was markedly lower.

The crucial difference in experimental conditions between U937 monocytes and HeLa epithelial cells is the cellular character. In terms of the molecular expression pattern, such as receptors, these cells are very different. Epithelial cells express EGFR, which is capable of being activated by [21, 22]. Conversely, monocytes do not express EGFR. Consequently, the receptor may be different between monocytes and epithelial cells.

We subsequently examined the inhibitory effect of o-phenanthroline on IL-8 production in HeLa cells. IL-8 production was upregulated in -treated HeLa cells. In contrast, its production was significantly downregulated in -treated HeLa cells with in comparison to those without o-phenanthroline. These results demonstrate that the o-phenanthroline-dependent downregulation of Erk pathway is sufficient to suppress IL-8 production in epithelial cells upon -mediated inflammation.

The iron balance is another key determinant in chemokine production. As Fe2+, iron is a stronger redox molecule than calcium, an effect that is likely mediated by an increase in the presence of iron. However, the shortage of iron affects the observed IL-8 production in very different ways. In the case of -phenanthroline or DFO itself, a chelator for Fe ion, induced IL-8 production in epithelial cells [23]. The mechanism by which DFO or -phenanthroline induces IL-8 production has remained unknown.

Inflammation is associated with disease progression. Recent reports have described an -independent role of metal ions in chemokine production in epithelial cells [5]. However, the role of the oxidative pathway in chemokine production has until now remained unknown. Herein, we have shown that -induced chemokine production in epithelial cells is increased owing in part to the -mediated oxidation of iron.

References

  1. L. Fialkow, Y. Wang, and G. P. Downey, “Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function,” Free Radical Biology and Medicine, vol. 42, no. 2, pp. 153–164, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. P. A. J. Henricks and F. P. Nijkamp, “Reactive oxygen species as mediators in asthma,” Pulmonary Pharmacology and Therapeutics, vol. 14, no. 6, pp. 409–421, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Google Scholar · View at Scopus
  4. K. Z. Guyton, Y. Liu, M. Gorospe, Q. Xu, and N. J. Holbrook, “Activation of mitogen-activated protein kinase by H2O2: role in cell survival following oxidant injury,” Journal of Biological Chemistry, vol. 271, no. 8, pp. 4138–4142, 1996. View at Google Scholar · View at Scopus
  5. Y.-M. Kim, W. Reed, W. Wu, P. A. Bromberg, L. M. Graves, and J. M. Samet, “Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells,” American Journal of Physiology, vol. 290, no. 5, pp. L1028–L1035, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. Yamamoto, S. Shimizu, S. Kiyonaka et al., “TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration,” Nature Medicine, vol. 14, no. 7, pp. 738–747, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. A. R. St. John, Y. Li, X. Zhou et al., “Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 130, no. 8, pp. 929–935, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. E. J. Franzmann, E. P. Reategui, K. L. Carraway, K. L. Hamilton, D. T. Weed, and W. J. Goodwin, “Salivary soluble CD44: a potential molecular marker for head and neck cancer,” Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 3, pp. 735–739, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. D. Sidransky, “Emerging molecular markers of cancer,” Nature Reviews Cancer, vol. 2, no. 3, pp. 210–219, 2002. View at Google Scholar · View at Scopus
  10. W. Tan, L. Sabet, Y. Li et al., “Optical protein sensor for detecting cancer markers in saliva,” Biosensors and Bioelectronics, vol. 24, no. 2, pp. 266–271, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. A. Arenberg, S. L. Kunkel, P. J. Polverini, M. Glass, M. D. Burdick, and R. M. Strieter, “Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice,” Journal of Clinical Investigation, vol. 97, no. 12, pp. 2792–2802, 1996. View at Google Scholar · View at Scopus
  12. Y. Mizukami, W.-S. Jo, E.-M. Duerr et al., “Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells,” Nature Medicine, vol. 11, no. 9, pp. 992–997, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. Fujimoto, H. Sakaguchi, I. Aoki, and T. Tamaya, “Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers,” Cancer Research, vol. 60, no. 10, pp. 2632–2635, 2000. View at Google Scholar · View at Scopus
  14. C. Josse, J. R. Boelaert, M. Best-Belpomme, and J. Piette, “Importance of post-transcriptional regulation of chemokine genes by oxidative stress,” Biochemical Journal, vol. 360, no. 2, pp. 321–333, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zeng, J. Dai, D. G. Remick, and X. Wang, “Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes,” Circulation Research, vol. 93, no. 4, pp. 311–320, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L.-L. Chiu, D.-W. Perng, C.-H. Yu, S.-N. Su, and L.-P. Chow, “Mold allergen, Pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2,” Journal of Immunology, vol. 178, no. 8, pp. 5237–5244, 2007. View at Google Scholar · View at Scopus
  17. E. Cadenas, “Biochemistry of oxygen toxicity,” Annual Review of Biochemistry, vol. 58, pp. 79–110, 1989. View at Google Scholar · View at Scopus
  18. P. Méndez-Samperio, J. Palma-Barrios, A. Vázquez-Hernández, and E. García-Martínez, “Secretion of interleukin-8 by human-derived cell lines infected with Mycobacterium bovis,” Mediators of Inflammation, vol. 13, no. 1, pp. 45–49, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. Katakura, I. Kamiyama, N. Takano et al., “Comparison of salivary cytokine levels in oral cancer patients and healthy subjects,” The Bulletin of Tokyo Dental College, vol. 48, no. 4, pp. 199–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Hara, M. Wakamori, M. Ishii et al., “LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death,” Molecular Cell, vol. 9, no. 1, pp. 163–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zhougang and R. G. Schnellmann, “H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells,” American Journal of Physiology, vol. 286, no. 5, pp. F858–F865, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. Y. S. Bae, S. W. Kang, M. S. Seo et al., “Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation,” Journal of Biological Chemistry, vol. 272, no. 1, pp. 217–221, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. E.-Y. Choi, Z.-Y. Park, E.-J. Choi et al., “Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-κB but involves ERK1/2- and p38 kinase-dependent activation of AP-1,” Journal of Cellular Biochemistry, vol. 102, no. 6, pp. 1442–1457, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus